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Abstract
Background: Migraine is underdiagnosed especially by general practitioners and non-neurologists. In our experience,
validated screening and diagnosing tools for migraine are generally not used outside neurology. The three-item identi-
fication of migraine (ID-Migraine™) is a short and validated screening/diagnosing tool; positive predictive value for
migraine is 93% if at least two out of nausea, photophobia, or disability are present.
Aim: To investigate the diagnostic yield of ID-Migraine™ when applied to the information provided in the referral letters.
Methods: Retrospective analysis of 95 referral letters of patients referred for undetermined headache who were finally
diagnosed with migraine at our Tertiary Care Headache Center.
Results: Median age was 34 years, and 75% were women. Migraine was suspected by the referring physician in 33% of
patients, whereas the remainder were classified as unclear. ID-Migraine™ criteria were fulfilled in 59% of patients with
referral diagnosis of suspected migraine and 23% of patients with unclear headache, respectively. Clinical characteristics
associated with migraine suspicion were photophobia and other visual symptoms.
Conclusion: Applying ID-Migraine™ in primary care, emergency departments, or in specialists’ consultations outside
neurology might lead to an increased frequency of migraine recognition. Knowledge about and access to those criteria
should be increased, especially in the primary care setting.
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Introduction
At our University Hospital Headache Clinic, we regularly
observe that patients are referred for further evaluation of
“undetermined headache,” even though the diagnosis of
migraine without aura could have been made solely from
the information provided in the referral letter. The refer-
ence standard for migraine diagnosis, the diagnostic criteria
by the International Headache Society (IHS),1 are basically
never used by our referring physicians. One might specu-
late that those criteria might not be feasible in clinical
practice for many due to lack of time during consultations.
Another reason might be that most non-neurologists might
not know about their existence. However, other screening/
diagnosing tools are only very rarely used either, even
though different brief, easy-to-use, and validated tools to
screen for migraine in the primary care setting exist, among
them the three-item identification of migraine
(ID-Migraine™).2,3 Positive predictive value for migraine
is 93% if at least two out of the following three symp-
toms are present: nausea, photophobia, or disability.2
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ID-Migraine™ was recommended to be used in different
settings including the primary care setting.4
Against this background, we aimed at evaluating the
potential diagnostic yield of ID-Migraine™ by analyzing
the information provided in the referral letters.
Methods
This retrospective study analyzes referral letters. Inclu-
sion criteria were patients older than 16 years, first-time
referral to the Headache Clinic of the University Hospi-
tal Bern, referral between May 2014 and October 2017
for evaluation of undetermined headache, and final diag-
nosis of migraine without aura according to ICHD
3-beta criteria.5 Since in our experience, migraine with-
out aura is more often misdiagnosed or not recognized
than migraine with aura, we have focused on this in our
opinion more neglected and obviously more-difficult-to-
diagnose disorder.
All patients who presented to the Headache Clinic were
asked to sign a written informed consent (i.e. general con-
sent) that allows the use of their health-related clinical data
for national and international research projects on investi-
gation, prevention, diagnosis, and treatment of diseases.
Only patients who accepted the general consent were
included in this study. Exclusion criteria were other final
diagnosis than episodic migraine without aura, established
diagnosis of migraine prior to referral, lack of general con-
sent, or unavailable referral letter (i.e. not found in spite of
extensive search in electronic patient records).
Study data were collected and managed using the RED-
Cap electronic data capture tool hosted at the University
Hospital Bern.6 The following data were collected from the
referral letters: gender; age; referring institution (general
practitioner (GP), specialist, university hospital, peripheral
hospital); specialty of referring physician; referral diagno-
sis; disability (impairment in social, professional, or famil-
iar functioning); presence of phonophobia, photophobia,
nausea, vomiting, dizziness, paresthesia, visual symptoms
other than photophobia; aggravation by physical activity;
and pain characteristics (intensity, quality, duration, loca-
lization, laterality). Furthermore, we evaluated whether
IHS criteria for migraine without aura or migraine-
specific screening tools were used by the referring doctor.
Ethics review board approval
The study was approved by Swissethics, the Swiss Ethics
Committees on research involving humans.
Statistical analysis
Associations between referral diagnosis (suspected
migraine or unknown) and clinical variables were
assessed using the Wilcoxon rank-sum test for continuous
variables, and using the w2 or the Fisher’s exact test, as
appropriate, for categorical variables. All tests were two-
sided with a significance level of 0.05. Statistical analysis
was performed using R, version 3.3.1 (R Core Team 2018,
Vienna, Austria). Results are expressed as numbers and
percentages for categorical variables, and as a median
[25th percentile; 75th percentile] for continuous variables,
according to their distribution.
Results
During the 42 months’ period, 95 referral letters fulfilled
the inclusion criteria (Figure 1).
Figure 1. Flow chart illustrating inclusion procedure.
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In 32 patients (33.7%), migraine was suspected by
the referring physician, whereas in the other patients,
the headache disorder was classified as unknown
(Table 1). Median age was 34 years, and 71 (74.7%)
were women. Most patients had been referred by the
University Hospital (n ¼ 48, 50.5%) or GPs (n ¼ 42,
44.2%). Most referrals from the University Hospital
came from the interdisciplinary emergency, gynecol-
ogy, and internal medicine departments. No referring
physician indicated the use of any migraine screening
or diagnosing tools.
Table 2 shows patient characteristics according to
referral diagnosis. Headache interference with work-
ing, family, or social functions was high in both
groups, ranging from 90% to 100%. Photophobia and
visual disorders other than photophobia were signifi-
cantly more frequent in the suspected migraine group.
The prevalence of dizziness, nausea, and pulsating
pain in that group tended to be higher. Pain intensity,
duration, and laterality did not differ significantly
between groups.
ICHD 3-beta criteria for migraine were fulfilled in three
referral letters (9.4%) in the suspected migraine group and
in two (3.2%) in the group of unknown headache disorder
(p ¼ 0.33). ID-Migraine™ criteria were fulfilled in 19
(59.4%) referral letters in the suspected migraine group and
in 15 (23.8%) in the unclear headache disorder group
(p < 0.001).
Table 1. Characteristics of the study population.a
Study population (n ¼ 95)
Age, years 34 [24; 46]
Sex, male 24 (25.3%)
Referred from
GP 42 (44.2%)
Peripheral hospital 2 (2.1%)
Specialist 3 (3.2%)
University hospital 48 (50.5%)
Referral diagnosis
Suspected migraine 32 (33.7%)
Unknown 63 (66.3%)
GP: general practitioner.
aValues shown are median [25th percentile; 75th percentile] and numbers
(percentages).
Table 2. Characteristics of the study population according to referral diagnosis.a
Characteristic
Suspected migraine
(n ¼ 32) MD
Unknown
(n ¼ 63) MD p Value
Age, years 36.5 [26.0; 48.3] — 32.0 [23.5; 46.0] — 0.33
Sex, male 8 (25.0%) — 16 (25.4%) — 0.97
Interference with working, family, or social functions 15 (100.0%) 17 18 (90.0%) 43 0.50
Accompanying symptoms
Phonophobia 9 (42.9%) 11 10 (26.3%) 25 0.19
Photophobia 13 (61.9%) 11 13 (34.2%) 25 0.04
Nausea 16 (76.2%) 11 20 (52.6%) 25 0.08
Vomiting 8 (38.1%) 11 11 (28.9%) 25 0.67
Dizziness 6 (28.6%) 11 4 (10.5%) 25 0.08
Paresthesia 2 (9.5%) 11 0 (0.0%) 25 0.12
Visual symptoms other than photophobia 5 (23.8%) 11 1 (2.6%) 25 0.02
Other 4 (19.0%) 11 4 (10.5%) 25 0.44
None 0 (0.0%) 11 7 (18.4%) 25 0.04
Pain intensity (NRS) 9 [8; 9] 23 8 [7; 9] 51 0.21
Pain quality
Pulsating 8 (66.7%) 20 7 (43.8%) 47 0.99
Oppressive 4 (33.3%) 20 6 (37.5%) 47 0.99
Other 4 (33.3%) 20 6 (37.5%) 47 0.99
Pain duration (untreated or unsuccessfully treated), hours 20 46 0.62
<4 0 2 (11.8%)
4–72 11 (91.7%) 13 (76.5%)
72 1 (8.3%) 2 (11.8%)
Pain laterality 18 23
Strictly unilateral 5 (15.6%) 19 (30.2%) 0.12
Unilateral but changing sides between attacks 1 (3.1%) 2 (3.2%) 0.99
Bilateral 8 (25.0%) 19 (30.2%) 0.60
ICHD 3-beta criteria for migraine without aura fulfilled in referral letter 3 (9.4%) — 2 (3.2%) — 0.33
ID-MigraineTM criteria fulfilled in referral letter 19 (59.4%) — 15 (23.8%) — <0.001
MD: missing data; NRS: numerical rating scale (1–10/10); ICHD 3-beta: International Classification of Headache Disorders, 3rd edition, beta version;
ID-MigraineTM three-item identification of migraine.
aValues shown are median [25th percentile; 75th percentile] and numbers (percentages).
P-values < 0.05 are bold-faced.
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Discussion
Although migraine is a very frequent disorder with an enor-
mous burden of disease,7 it is underdiagnosed by GPs (and
other physicians).8 The reasons for this might be manifold.
The results of the present analysis of referral letters of
patients referred for the evaluation of “undetermined head-
ache” who were finally diagnosed with migraine without
aura according to the IHS criteria5 indicate that one impor-
tant reason seems to be a lack of knowledge about key
migraine features. This translates into an important per-
centage of fulfilled ID-Migraine™ criteria when analyzing
only the information provided in referral letters, which
generally are not very detailed. Referring physicians are
not required to provide particular information in referring
letters to refer a patient to our headache clinic except for
personal data, which leads to great differences as far as
information about patient’s conditions is concerned, and
which led to the high amount of missing data in our study.
Yet referring physicians seem to ask after key anamnestic
features such as disability, photophobia, and nausea (i.e.
the ID-Migraine™ criteria), but seem to fail to fully
recognize their meaning in patients with presumably
undetermined/unclear headache: While visual symptoms
were associated with suspicion of migraine in the pres-
ent study, disability and nausea were not. On the other
hand, neurologists and neurological societies obviously
seem to fail to sufficiently spread the knowledge on
practical, short, and validated migraine screening/diag-
nosing tools such as ID-Migraine™.
In our opinion, the present study setting represents the
real-world situation of specialized headache centers, thus
our results are likely to be generalizable. One important
limitation is the high amount of missing data, also reflect-
ing a real-world situation where amount and accuracy of
information provided varies widely.
Conclusion
Applying ID-Migraine™ in primary care, in specialists’
consultations outside neurology, or in other settings where
there is no neurologist and a lack of time might lead to an
increased frequency of migraine recognition. Knowledge
about and access to those criteria should be increased, for
example, by awareness campaigns of national headache
societies or via patient organizations. Evaluation of key
migraine features such as photophobia/visual symptoms,
nausea, or disability associated with headache attacks could
even be done before consultation, even by a nurse practi-
tioner, probably increasing efficacy during consultation.
Also, standardized referral forms to refer patients to the
headache clinic could be created, where ID-Migraine™
criteria could be mentioned to help referring doctors with
focusing on relevant clinical symptoms and at the same
time increasing migraine symptoms awareness.
Clinical implications
 Migraine remains an underdiagnosed disorder espe-
cially outside neurology.
 ID-Migraine™ is an easy-to-use and validated
screening tool, and its use should be promoted espe-
cially outside neurology consultations.
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